Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...

Heart failure (HF) is a chronic and progressive cardiovascular condition associated with significant morbidity, mortality and ...

Personalised vaccines will be tested on children with untreatable brain tumours as part of a world-first clinical trial across eight Australian pediatric hospitals in a major development in research.